idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
01.08.2016 11:48

Recovery Of Dopamine Function Emerges With Recovery From Smoking

Rüdiger Labahn Informations- und Pressestelle
Universität zu Lübeck

    Dr. Lena Rademacher, University of Lübeck, in “Biological Psychiatry”: The alterations in dopamine synthesis capacity normalized through abstinence

    A new study in “Biological Psychiatry” reports that smoking-related deficits in brain dopamine, a chemical implicated in reward and addiction, return to normal three months after quitting. The normalization of dopamine systems suggests smoking-related deficits are a consequence of chronic smoking, rather than a risk factor. These findings raise the possibility that treatments might be developed that normalize the dopamine system in smokers.

    According to first author Dr. Lena Rademacher, Postdoctoral fellow at the University of Lübeck, Germany, a major challenge in understanding substance-related disorders lies in uncovering why only some individuals become addicted.

    Researchers think some people could possess a trait that predisposes them to addiction, and suspect that brain circuits involving dopamine may be involved. Drugs of abuse release dopamine, and addiction to nicotine is associated with abnormalities in the dopamine system. But researchers are uncertain if smoking induces those abnormalities or if they already exist and contribute to risk of nicotine addiction.

    Senior author Dr. Ingo Vernaleken, Professor at RWTH Aachen University, Germany led a team of researchers examining dopamine function in chronic smokers before and after long-term cessation. The researchers used a brain imaging technique called positron emission tomography to measure an index of the capacity for dopamine production in 30 men who were nicotine-dependent smokers and 15 nonsmokers. After performing an initial scan on all participants, 15 smokers who successfully quit were scanned again after three months of abstinence from smoking and nicotine replacement.

    The initial scan revealed a 15–20% reduction in the capacity for dopamine production in smokers compared with nonsmokers. The researchers expected this impairment to persist even after quitting, which would suggest it could be a marker of vulnerability for nicotine addiction. “Surprisingly, the alterations in dopamine synthesis capacity normalized through abstinence,” said Rademacher.
    The role of dopamine in vulnerability toward nicotine addiction cannot be excluded, but the findings suggest that altered dopamine function of smokers is a consequence of nico-tine consumption rather than the cause.

    Dr. John Krystal, Editor of “Biological Psychiatry”, noted the implications of these findings for developing better ways to help smokers trying to quit. “This study suggests that the first three months after one stops smoking may be a particularly vulnerable time for relapse, in part, because of persisting dopamine deficits. This observation raises the possibility that one might target these deficits with new treatments.”

    The article is "Effects of Smoking Cessation on Presynaptic Dopamine Function of Addicted Male Smokers" by Lena Rademacher, Susanne Prinz, Oliver Winz, Karsten Hen-kel, Claudia A. Dietrich, Jörn Schmaljohann, Siamak Mohammadkhani Shali, Ina Schabram, Christian Stoppe, Paul Cumming, Ralf-Dieter Hilgers, Yoshitaka Kumakura, Mark Coburn, Felix M. Mottaghy, Gerhard Gründer, and Ingo Vernaleken (doi: 10.1016/j.biopsych.2015.11.009). It appears in Biological Psychiatry, volume 80, issue 3 (2016), published by Elsevier.

    Journalists wishing to interview the authors may contact Lena Rademacher at Rademacher@snl.uni-luebeck.de.

    Biological Psychiatry is the official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. Biological Psychiatry is one of the most selective and highly cited journals in the field of psychiatric neuroscience. It is ranked 5th out of 140 Psychiatry titles and 11th out of 256 Neurosciences titles in the Journal Citations Reports® published by Thomson Reuters. The 2015 Impact Factor score for Biological Psychiatry is 11.212. Media contact: Rhiannon Bugno, biol.psych@utsouthwestern.edu


    Bilder

    Figure 1. Interindividual group differences in dopamine synthesis capacity
    Figure 1. Interindividual group differences in dopamine synthesis capacity
    (Rademacher et al.)
    None

    Figure 2. Significant intraindividual changes in dopamine storage capacity
    Figure 2. Significant intraindividual changes in dopamine storage capacity
    (Rademacher et al.)
    None


    Merkmale dieser Pressemitteilung:
    Journalisten, Wissenschaftler
    Biologie, Medizin, Psychologie
    überregional
    Forschungsergebnisse
    Englisch


     

    Figure 1. Interindividual group differences in dopamine synthesis capacity


    Zum Download

    x

    Figure 2. Significant intraindividual changes in dopamine storage capacity


    Zum Download

    x

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).